apitegromab tirzepatide A new phase 2 trial in Nature Medicine tested whether apitegromab, an investigational monoclonal antibody that selectively inhibits myostatin activation, could preserve lean mass during… apitegromab tirzepatide New Drug Could
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17





















